Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Is vitamin e or ursodeoxycholi...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016?

Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016?

Bibliographic Details
Main Authors: Melanie D Beaton, Bandar Al-Judaibi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:The Saudi Journal of Gastroenterology
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2016;volume=22;issue=3;spage=169;epage=170;aulast=Beaton
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2016;volume=22;issue=3;spage=169;epage=170;aulast=Beaton

Similar Items

  • Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    by: Melanie D Beaton
    Published: (2012-01-01)
  • Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
    by: Murat Kiyici, et al.
    Published: (2003-01-01)
  • A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
    by: V.N. Santos, et al.
    Published: (2003-06-01)
  • Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial
    by: Nahum Méndez-Sánchez, et al.
    Published: (2004-07-01)
  • Review: Treatment options for nonalcoholic fatty liver disease
    by: Brian Lam, et al.
    Published: (2010-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs